China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
HAIKOU CITY, China, Nov. 4 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), a specialty pharmaceutical company which develops, manufactures, and markets its products in China,which develops, manufactures, and markets generic and brande...
China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination
China's SFDA Approves Entry into Clinical Trials on Schedule HAIKOU CITY, China, Oct. 29 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China...
China Pharma Holdings, Inc. Appoints The Ruth Group
Leading IR Consultancy for Emerging Chinese Companies HAIKOU CITY, Hainan, China, Oct. 21 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets generic and branded bio-pharmaceutical products in Chin...
China Pharma Holdings, Inc. Projects Clear Improvements in Operating Cash Flow for the 3rd Quarter 2008 and Indicates Readiness for Upgrading to AMEX
NEW YORK and HAIKOU CITY, China, Sept. 22 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma”) (OTC Bulletin Board: CPHI) which develops, manufactures, and markets specialty pharmaceutical products in China, announced today that it projects a clearly improved Operatin...
China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
Revenue Guidance with Q3 2008 Forecasts Growth of More Than 40% NEW YORK and HAIKOU CITY, Hainan, China, Sept. 18 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma”) (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and brand bio-pharma...
China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) 'Beijing Management Summit'
HAIKOU, Hainan, China, Sept. 1 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio/pharmaceutical products in China, today announced attendance at the Susquehanna Financial ...
China Pharma Holdings, Inc. Announces Second Quarter 2008 Financial Results
NEW YORK and HAIKOU CITY, China, Aug. 6 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced its financial results for the s...
China Pharma Holdings, Inc. to Host Second Quarter 2008 Earnings Conference Call at 10 a.m. EDT Wednesday August 6, 2008
NEW YORK and HAIKOU, China, Aug. 1 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma”) (OTC Bulletin Board: CPHI) which develops, manufactures, and markets leading off-patent brand and newly developed products in China, today announced the Company will host an earning...
China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT
NEW YORK and HAIKOU CITY, China, July 3 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. (“China Pharma”) (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced that the management will present at the Colli...
China Pharma Holdings, Inc. Closes $10 Million Financing
HAIKOU CITY, Hainan, China, May 31 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma" or "Company") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced that on May 30, 2008 it closed its re...
China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million
HAIKOU CITY, Hainan, China, May 28 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma” or “Company”) (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced that it has entered into ...
China Pharma Holdings, Inc. Donates Medicine for Sichuan Earthquake Relief
NEW YORK and HAIKOU, China, May 16 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and brand bio-pharmaceutical products in China, announced today that it donated 2 million RMB (approximately US$285,...
China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results
-- Quarterly Revenues Increase 62% to $11.7 million -- Quarterly Net Income Increases 76.5% to $4.2 million with EPS of $0.11 NEW YORK and HAIKOU, Hainan, China, May 2 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma”) (OTC Bulletin Board: CPHI) which develops, m...
China Pharma Holdings, Inc. Pre-Announces First Quarter 2008
Revenue and Net Income Growth in Excess of 60 Percent Compared to First Quarter 2007 Company to Host First Quarter 2008 Earnings Conference Call at 10 a.m. EDT on Tuesday, May 6, 2008 NEW YORK and HAIKOU, China, April 29 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (...
China Pharma Holdings, Inc. Announces Record 2007 Year End Results
-- Fiscal year Revenue Increased 51.9% to $33.2 Million -- Fiscal year Net Income Increased 49.3% to $12.8 Million -- The Company Provides Guidance of 40% Growth in Revenue for 2008 NEW YORK and HAIKOU, Hainan, China, March 31 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Ho...
China Pharma Holdings, Inc. Announces Earnings Call for Fiscal 2007 Financial Results
- March 31, 2008 at 11:00 a.m. EDT NEW YORK and HAIKOU CITY, China, March 27 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced i...
China Pharma Holdings, Inc. Receives $5.6 Million in Purchase Orders for Pusen OK (Generic Aleve-D(TM) Product)
The Company Announces Unaudited Preliminary 2007 Revenue of Approximately $33 Million, Representing an Over 50% Increase From 2006 NEW YORK and HAIKOU, China, Feb. 25 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, man...
China Pharma Appoints Three Independent Non-Executive Directors
- Three New Board Members to Form Audit Committee NEW YORK and HAIKOU, China, Feb. 6 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and brand bio-pharmaceutical products in China, today announced...
China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection
-- The Approval Creates New Growth Opportunities for the Company -- Potentially Denotes a Positive Sign Related to the SFDA Drug Approval Process NEW YORK and HAIKOU, China, Jan. 29 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI)...
China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
NEW YORK and HAIKOU, China, Jan. 14 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma”) (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and brand bio-pharmaceutical products in China, today announced that it has retained HC International...
